Benzinga's Top Pre-Market NASDAQ Losers (XOMA, VECO, CREE, AIXG)

XOMA Ltd XOMA dipped 36.25% to $3.20 in the pre-market session. XOMA reported that its potential diabetes treatment failed to lower blood sugar in a mid-stage study. Veeco Instruments Inc VECO lost 6.73% to $46.01 in the pre-market session. VECO's trailing-twelve-month ROA is 19.77% Cree Inc CREE moved down 6.35% to $45.89 in the pre-market session. CREE lowered its FQ3 revenue projections to a range of $215 million to $220 million. Aixtron SE AIXG fell 3.81% to $40.10 in the pre-market trading. AIXG's trailing-twelve-month profit margin is 24.56%. Read more from Benzinga's Markets.